Long-acting B-agonist (LABA) monotherapy among patients with asthma is rare. Of those with continued LABA monotherapy, most had missed opportunities for therapy change or education.

Please provide your email address to receive an email when new articles are posted on . “Asthma care in the Netherlands is divided between different health care providers, including respiratory ...

Beta2 (ß2)-agonist medications are a type of inhaled bronchodilator used to treat asthma. In the pathophysiology of asthma, tightened airways cause wheezing, chest tightness, shortness of breath ...

Patients with severe asthma are at increased risk for a decreased quality of life, fixed airway obstruction, hospitalization, and death. Biologics may be required to reduce the disease burden. This ...

Ye X, Gutierrez B, Zarotsky V, et al. Appropriate use of inhaled corticosteroid and long-acting beta (2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured ...

An inhaled beta-2 agonist is also the most effective means of prophylaxis for exercise-induced bronchospasm. Careful instruction regarding appropriate use of the prescribed device is essential.

Etokimab (I-Mab Biopharma), which is optimized for common IL-33 gene polymorphisms, has completed patient recruitment in its ...

ICS combined with short-acting β agonists and ICS combined with the long-acting β agonist formoterol are each associated with reduced asthma exacerbations compared with SABA alone.

The researchers discovered a molecule that can increase the potency of one of the main ingredients in asthma inhalers (beta agonist), whose purpose is to relax airway smooth muscle and open up ...

Exposure to beta-2-adrenergic receptor agonists in utero increased the risk of developing autism spectrum disorders, new research shows.